JPRN-UMIN000020206招募中2 期
High-dose-rate brachytherapy as monotherapy for intermediate- and high-risk prostate cancer: A phase II clinical trial - Monotherapeutic HDR-BT for intermediate- and high-risk prostate cancer: Phase II
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Active other malignancy 2) Uncontrollable diabetes mellitus 3) Unstoppable anticoagulant drugs 4) Severe neurocognitive disease 5) Collagen disease 6) Previous surgery or irradiation to the pelvis 7) Previous TUR-P 8) Severe BPH or lower urinaly tract symptoms 9) Low-risk prosatate cancer 10) High-risk prostate cancer with all 3 factors of T3-4, GS >=, and PSA >=20 11) Neoadjucant hormone therapy >1 year 12) Castration-resistant prostate cancer 13) The physician juddged contraindication
研究者
相似试验
已完成
不适用
Single fraction high-dose-rate brachytherapy monotherapy in prostate cancer * Phase I-II triallow-risk prostate cancerprostate carcinoma10038364NL-OMON46332Erasmus MC, Universitair Medisch Centrum Rotterdam10
招募中
2 期
Focal therapy with low dose rate brachytherapy for localized prostate cancerJPRN-UMIN000015071Department of Urology, Tokyo Medical and Dental University200
招募中
Unknown
High-Dose Internal Radiation Therapy Alone for Soft Tissue Cancer in Limbs: A Study PlaCTRI/2024/06/068831All India Institute of Medical Sciences Jodhpur
已完成
不适用
RObotic mri-guided high dose rate Brachytherapy Needle implantation in the proState - a proof of concept studyprostatic carcinoma100385971003695810025506Prostate cancerNL-OMON55715niversitair Medisch Centrum Utrecht5
招募中
不适用
Robot-gestuurde plaatselijke inwendige bestraling voor de behandeling van patiënten met teruggekeerde prostaatkanker.NL-OMON26571niversity Medical Center Utrecht (UMCU)5
